ANVISA-2020-0085-V485

Type II variation for application ANVISA-2020-0085. Type II variation: Labeling Change for Immunovant-α — minor update

Variation Number
ANVISA-2020-0085-V485
Type
Type II
Application
ANVISA-2020-0085
Change
CHG-2024-0185
Status
Completed
Fee
€38,377
Submitted
2024-04-25
Approved
—
Description

Type II variation: Labeling Change for Immunovant-α — minor update